Which has preferable earnings and valuation, COO or ALC?

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Cooper Companies $4.23B 3.49 $374.90M $1.18 64.20 Alcon $10.86B 3.36 $980M $1.31 56.24

Does the media refer more to COO or ALC?

In the previous week, Cooper Companies had 7 more articles in the media than Alcon. MarketBeat recorded 18 mentions for Cooper Companies and 11 mentions for Alcon. Cooper Companies' average media sentiment score of 0.76 beat Alcon's score of 0.46 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 6 Very Positive mention(s) 6 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Alcon 3 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer COO or MDLN?

In the previous week, Medline had 7 more articles in the media than Cooper Companies. MarketBeat recorded 25 mentions for Medline and 18 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.76 beat Medline's score of 0.17 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 6 Very Positive mention(s) 6 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Medline 5 Very Positive mention(s) 3 Positive mention(s) 10 Neutral mention(s) 4 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer COO or WST?

In the previous week, Cooper Companies and Cooper Companies both had 18 articles in the media. Cooper Companies' average media sentiment score of 0.76 beat West Pharmaceutical Services' score of 0.62 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 6 Very Positive mention(s) 6 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive West Pharmaceutical Services 4 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor COO or SOLV?

In the previous week, Cooper Companies had 14 more articles in the media than Solventum. MarketBeat recorded 18 mentions for Cooper Companies and 4 mentions for Solventum. Solventum's average media sentiment score of 1.05 beat Cooper Companies' score of 0.76 indicating that Solventum is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 6 Very Positive mention(s) 6 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive Solventum 2 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to ALGN or COO?

In the previous week, Cooper Companies had 7 more articles in the media than Align Technology. MarketBeat recorded 18 mentions for Cooper Companies and 11 mentions for Align Technology. Cooper Companies' average media sentiment score of 0.76 beat Align Technology's score of 0.46 indicating that Cooper Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 5 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 3 Negative mention(s) 0 Very Negative mention(s) Neutral Cooper Companies 6 Very Positive mention(s) 6 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Positive

Cooper Companies (COO) Competitors

$75.76 +0.66 (+0.88%)

Closing price 04:00 PM Eastern

Extended Trading

$75.56 -0.20 (-0.27%)

As of 05:23 PM Eastern

Compare

COO vs. ALC, MDLN, WST, SOLV, and ALGN

Should you buy Cooper Companies stock or one of its competitors? Cooper Companies's main competitors and comparable companies include Alcon (ALC), Medline (MDLN), West Pharmaceutical Services (WST), Solventum (SOLV), and Align Technology (ALGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Cooper Companies compare to Alcon?

Cooper Companies (NASDAQ:COO) and Alcon (NYSE:ALC) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.20
Alcon	$10.86B	3.36	$980M	$1.31	56.24

In the previous week, Cooper Companies had 7 more articles in the media than Alcon. MarketBeat recorded 18 mentions for Cooper Companies and 11 mentions for Alcon. Cooper Companies' average media sentiment score of 0.76 beat Alcon's score of 0.46 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	6 Very Positive mention(s)	6 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Alcon	3 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Alcon has a net margin of 5.92% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.88% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
Alcon	5.92%	7.29%	5.09%

Cooper Companies has a beta of 0.83, meaning that its share price is 17% less volatile than the broader market. Comparatively, Alcon has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market.

Cooper Companies currently has a consensus target price of $81.64, indicating a potential upside of 7.77%. Alcon has a consensus target price of $84.63, indicating a potential upside of 14.87%. Given Alcon's stronger consensus rating and higher probable upside, analysts clearly believe Alcon is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Alcon	1 Sell rating(s)	7 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.60

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 53.9% of Alcon shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Summary

Alcon beats Cooper Companies on 9 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Medline?

Cooper Companies (NASDAQ:COO) and Medline (NASDAQ:MDLN) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, profitability, institutional ownership, earnings, risk, valuation, analyst recommendations and dividends.

Medline has higher revenue and earnings than Cooper Companies. Medline is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.20
Medline	$28.43B	1.58	$1.16B	$0.79	43.19

Cooper Companies has a net margin of 5.57% compared to Medline's net margin of 0.00%. Cooper Companies' return on equity of 10.88% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
Medline	N/A	N/A	N/A

Cooper Companies presently has a consensus target price of $81.64, suggesting a potential upside of 7.77%. Medline has a consensus target price of $47.42, suggesting a potential upside of 38.99%. Given Medline's stronger consensus rating and higher probable upside, analysts clearly believe Medline is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83

In the previous week, Medline had 7 more articles in the media than Cooper Companies. MarketBeat recorded 25 mentions for Medline and 18 mentions for Cooper Companies. Cooper Companies' average media sentiment score of 0.76 beat Medline's score of 0.17 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	6 Very Positive mention(s)	6 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Medline	5 Very Positive mention(s)	3 Positive mention(s)	10 Neutral mention(s)	4 Negative mention(s)	0 Very Negative mention(s)	Neutral

24.4% of Cooper Companies shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 0.8% of Medline shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Summary

Cooper Companies beats Medline on 9 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to West Pharmaceutical Services?

Cooper Companies (NASDAQ:COO) and West Pharmaceutical Services (NYSE:WST) are both large-cap healthcare companies, but which is the superior stock? We will contrast the two businesses based on the strength of their institutional ownership, earnings, profitability, risk, analyst recommendations, valuation, dividends and media sentiment.

24.4% of Cooper Companies shares are held by institutional investors. Comparatively, 93.9% of West Pharmaceutical Services shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Comparatively, 0.6% of West Pharmaceutical Services shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Cooper Companies currently has a consensus price target of $81.64, indicating a potential upside of 7.77%. West Pharmaceutical Services has a consensus price target of $368.08, indicating a potential upside of 6.32%. Given Cooper Companies' higher probable upside, equities analysts plainly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.87

West Pharmaceutical Services has a net margin of 16.98% compared to Cooper Companies' net margin of 5.57%. West Pharmaceutical Services' return on equity of 20.11% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
West Pharmaceutical Services	16.98%	20.11%	14.83%

West Pharmaceutical Services has lower revenue, but higher earnings than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.20
West Pharmaceutical Services	$3.33B	7.32	$493.70M	$7.81	44.33

In the previous week, Cooper Companies and Cooper Companies both had 18 articles in the media. Cooper Companies' average media sentiment score of 0.76 beat West Pharmaceutical Services' score of 0.62 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	6 Very Positive mention(s)	6 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
West Pharmaceutical Services	4 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Cooper Companies has a beta of 0.83, suggesting that its share price is 17% less volatile than the broader market. Comparatively, West Pharmaceutical Services has a beta of 1.15, suggesting that its share price is 15% more volatile than the broader market.

Summary

West Pharmaceutical Services beats Cooper Companies on 10 of the 15 factors compared between the two stocks.

How does Cooper Companies compare to Solventum?

Cooper Companies (NASDAQ:COO) and Solventum (NYSE:SOLV) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

Cooper Companies presently has a consensus price target of $81.64, indicating a potential upside of 7.77%. Solventum has a consensus price target of $91.64, indicating a potential upside of 4.67%. Given Cooper Companies' higher probable upside, research analysts plainly believe Cooper Companies is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Solventum	1 Sell rating(s)	5 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.46

24.4% of Cooper Companies shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Comparatively, 0.2% of Solventum shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Solventum has a net margin of 17.26% compared to Cooper Companies' net margin of 5.57%. Solventum's return on equity of 25.09% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
Solventum	17.26%	25.09%	8.78%

Cooper Companies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market. Comparatively, Solventum has a beta of 0.6, suggesting that its stock price is 40% less volatile than the broader market.

In the previous week, Cooper Companies had 14 more articles in the media than Solventum. MarketBeat recorded 18 mentions for Cooper Companies and 4 mentions for Solventum. Solventum's average media sentiment score of 1.05 beat Cooper Companies' score of 0.76 indicating that Solventum is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	6 Very Positive mention(s)	6 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive
Solventum	2 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Solventum has higher revenue and earnings than Cooper Companies. Solventum is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.20
Solventum	$8.31B	1.79	$1.56B	$8.18	10.70

Summary

Cooper Companies and Solventum tied by winning 8 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations.

Align Technology has a net margin of 9.99% compared to Cooper Companies' net margin of 5.57%. Align Technology's return on equity of 15.86% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
Cooper Companies	5.57%	10.88%	7.27%

Align Technology has a beta of 1.65, indicating that its stock price is 65% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

Align Technology has higher earnings, but lower revenue than Cooper Companies. Align Technology is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.14B	2.91	$410.35M	$5.75	29.20
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.20

88.4% of Align Technology shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.8% of Align Technology shares are owned by company insiders. Comparatively, 2.1% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Align Technology currently has a consensus price target of $206.36, suggesting a potential upside of 22.90%. Cooper Companies has a consensus price target of $81.64, suggesting a potential upside of 7.77%. Given Align Technology's stronger consensus rating and higher probable upside, equities analysts clearly believe Align Technology is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

In the previous week, Cooper Companies had 7 more articles in the media than Align Technology. MarketBeat recorded 18 mentions for Cooper Companies and 11 mentions for Align Technology. Cooper Companies' average media sentiment score of 0.76 beat Align Technology's score of 0.46 indicating that Cooper Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	5 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	3 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cooper Companies	6 Very Positive mention(s)	6 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

Align Technology beats Cooper Companies on 10 of the 16 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COO vs. The Competition

Export

Metric	Cooper Companies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$14.78B	$5.79B	$7.08B	$12.84B
Dividend Yield	N/A	1.75%	2.56%	10.63%
P/E Ratio	64.20	26.07	269.82	24.68
Price / Sales	3.49	64.99	611.92	86.65
Price / Cash	12.58	33.83	28.87	38.47
Price / Book	1.83	6.03	11.30	6.46
Net Income	$374.90M	$149.25M	$3.45B	$347.37M
7 Day Performance	-1.38%	1.82%	1.13%	0.16%
1 Month Performance	5.65%	5.72%	2.56%	1.48%
1 Year Performance	3.03%	9.38%	62.53%	19.33%

Cooper Companies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COO Cooper Companies	2.2903 of 5 stars	$75.76 +0.9%	$81.64 +7.8%	+2.5%	$14.78B	$4.23B	64.20	15,000	Positive News
ALC Alcon	3.2568 of 5 stars	$74.23 +1.0%	$84.63 +14.0%	-17.5%	$36.72B	$10.40B	56.66	25,942	Analyst Forecast
MDLN Medline	3.2952 of 5 stars	$35.76 +0.5%	$47.42 +32.6%	N/A	$47.00B	$29.94B	45.28	45,000	Insider Trade
WST West Pharmaceutical Services	3.5616 of 5 stars	$346.73 +0.2%	$368.08 +6.2%	+40.8%	$24.40B	$3.07B	44.40	10,800
SOLV Solventum	2.8404 of 5 stars	$87.43 +1.1%	$91.64 +4.8%	+21.3%	$14.88B	$8.33B	10.69	20,000	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COO) was last updated on 8/18/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cooper Companies (COO) Competitors

COO vs. ALC, MDLN, WST, SOLV, and ALGN

How does Cooper Companies compare to Alcon?

Summary

How does Cooper Companies compare to Medline?

Summary

How does Cooper Companies compare to West Pharmaceutical Services?

Summary

How does Cooper Companies compare to Solventum?

Summary

How does Cooper Companies compare to Align Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COO vs. The Competition

Cooper Companies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cooper Companies (COO) Competitors

COO vs. ALC, MDLN, WST, SOLV, and ALGN

How does Cooper Companies compare to Alcon?

Which has preferable earnings and valuation, COO or ALC?

Does the media refer more to COO or ALC?

Is COO or ALC more profitable?

Which has more volatility & risk, COO or ALC?

Do analysts prefer COO or ALC?

Do insiders and institutionals believe in COO or ALC?

Summary

How does Cooper Companies compare to Medline?

Which has preferable valuation & earnings, COO or MDLN?

Is COO or MDLN more profitable?

Do analysts prefer COO or MDLN?

Does the media prefer COO or MDLN?

Do institutionals and insiders have more ownership in COO or MDLN?

Summary

How does Cooper Companies compare to West Pharmaceutical Services?

Do institutionals and insiders hold more shares of COO or WST?

Do analysts recommend COO or WST?

Is COO or WST more profitable?

Which has better earnings & valuation, COO or WST?

Does the media prefer COO or WST?

Which has more volatility & risk, COO or WST?

Summary

How does Cooper Companies compare to Solventum?

Do analysts rate COO or SOLV?

Do insiders & institutionals believe in COO or SOLV?

Is COO or SOLV more profitable?

Which has more risk and volatility, COO or SOLV?

Does the media favor COO or SOLV?

Which has stronger earnings & valuation, COO or SOLV?

Summary

How does Cooper Companies compare to Align Technology?

Is ALGN or COO more profitable?

Which has more risk and volatility, ALGN or COO?

Which has preferable earnings and valuation, ALGN or COO?

Do insiders and institutionals hold more shares of ALGN or COO?

Do analysts prefer ALGN or COO?

Does the media refer more to ALGN or COO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COO vs. The Competition

Cooper Companies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools